Artificial Intelligence in Clinical Decision-Making: Applications, Challenges, and Implications for Patient Safety
Main Article Content
Abstract
Artificial intelligence is increasingly positioned as a means of supporting diagnosis, predicting deterioration, selecting treatment, and organizing clinical information. Its contribution to patient safety, however, depends on the interaction between algorithms, professionals, patients, and healthcare organizations. This narrative review examines applications of artificial intelligence in clinical decision-making and develops a safety-oriented interpretation of the challenges surrounding implementation. Selected clinical studies, methodological publications, reporting guidelines, and international ethical guidance are discussed without claiming a systematic search or pooled estimate of effectiveness. Applications in diagnostic imaging, physiological monitoring, medication management, and language-based assistance illustrate both the opportunities and the limits of current approaches. Major hazards include unrepresentative data, inappropriate outcome proxies, poor calibration, distribution shift, automation bias, alert fatigue, privacy failures, and fabricated generative outputs. A hypothetical graph demonstrates how an apparently accurate alert can have low positive predictive value when the target condition is uncommon. A comparative table links application areas with plausible harms and practical safeguards. The review argues that predictive performance is an intermediate property rather than proof of patient benefit. Safe implementation requires explicit intended use, independent and local validation, prospective assessment of the clinician–system interaction, transparent communication of uncertainty, and continuous monitoring after deployment. Accountability must be distributed clearly across developers and healthcare institutions while preserving meaningful clinical responsibility. Artificial intelligence can strengthen clinical decision-making when its authority remains proportionate to its evidence and when institutions maintain reliable mechanisms for questioning, correcting, and withdrawing unsafe systems.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution 4.0 International License.
-
All published articles are open access, with copyright shared between the authors and the journal. The journal retains the exclusive right to first publication and identifies itself as original publisher.
-
Articles are made available under a Creative Commons CC BY‑NC‑ND 4.0 license, permitting users to copy and distribute the content for non‑commercial purposes only, without modification, provided proper credit is given to authors and JCPHS.
-
Redistribution or reuse must preserve the full citation details and include a link to the license. No derivatives, adaptations, or commercial uses are permitted without prior written permission.
References
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018). Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. npj Digital Medicine, 1, 39. https://doi.org/10.1038/s41746-018-0040-6
Cruz Rivera, S., Liu, X., Chan, A.-W., Denniston, A. K., & Calvert, M. J. (2020). Guidelines for clinical trial protocols for interventions involving artificial intelligence: The SPIRIT-AI extension. Nature Medicine, 26, 1351–1363. https://doi.org/10.1038/s41591-020-1037-7
Goh, E., et al. (2024). Large language model influence on diagnostic reasoning: A randomized clinical trial. JAMA Network Open, 7(10), e2440969. https://doi.org/10.1001/jamanetworkopen.2024.40969
Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine, 17, 195. https://doi.org/10.1186/s12916-019-1426-2
Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J., & Denniston, A. K. (2020). Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nature Medicine, 26, 1364–1374. https://doi.org/10.1038/s41591-020-1034-x
Nagendran, M., Chen, Y., Lovejoy, C. A., Gordon, A. C., Komorowski, M., Harvey, H., Topol, E. J., Ioannidis, J. P. A., Collins, G. S., & Maruthappu, M. (2020). Artificial intelligence versus clinicians: Systematic review of design, reporting standards, and claims of deep learning studies. BMJ, 368, m689. https://doi.org/10.1136/bmj.m689
Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453. https://doi.org/10.1126/science.aax2342
Topol, E. J. (2019). High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine, 25, 44–56. https://doi.org/10.1038/s41591-018-0300-7
Vasey, B., et al. (2022). Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nature Medicine, 28, 924–933. https://doi.org/10.1038/s41591-022-01772-9
Wong, A., et al. (2021). External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Internal Medicine, 181(8), 1065–1070. https://doi.org/10.1001/jamainternmed.2021.2626
World Health Organization. (2021). Ethics and governance of artificial intelligence for health: WHO guidance. https://www.who.int/publications/i/item/9789240029200
World Health Organization. (2024). Ethics and governance of artificial intelligence for health: Guidance on large multi-modal models. https://www.who.int/publications/b/70584